New drug access program offers hope for lewy body dementia patients
NCT ID NCT06961760
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This program gives people with mild-to-moderate dementia with Lewy bodies access to an experimental drug called CT1812 (Zervimesine) for up to one year. It aims to monitor long-term safety and how well the drug works. Participants must have completed a related study or be referred by their doctor with a confirmed diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Banner Sun Health Research Institute
Sun City, Arizona, 85351, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Mayo Clinic - Rochester
Rochester, Minnesota, 55905, United States
-
Ohio State University Wexner Medical Center (OSUWMC)
Columbus, Ohio, 43210, United States
-
Stanford Neuroscience Heath Center
Palo Alto, California, 94304, United States
-
Summit Headlands LLC
Portland, Oregon, 97210, United States
-
University of Colorado Denver - Anschutz Medical Campus
Aurora, Colorado, 80045, United States
-
University of Miami - Department of Neurology
Boca Raton, Florida, 33433, United States
Conditions
Explore the condition pages connected to this study.